World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
88
Citations
28021
World Ranking
1167
National Ranking
21

Medicine

D-Index
91
Citations
29006
World Ranking
11802
National Ranking
223

Overview

Jan Albert is affiliated with the Karolinska Institute in Sweden. Their research primarily spans the medical field with a focus on infectious diseases, epidemiology, virology, immunology, and cardiology and cardiovascular medicine. The work includes a substantial volume of publications related to SARS-CoV-2 and COVID-19 research, alongside studies on HIV and viral infections.

The scientist has published extensively, with key topics covered in their work including:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • SARS-CoV-2 detection and testing
  • Viral Infections and Immunology Research
  • Viral gastroenteritis research and epidemiology

Frequent publication venues for Jan Albert include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Lancet Infectious Diseases
  • Infectious Diseases
  • Eurosurveillance
  • Nature Communications

Some of the recent papers authored or coauthored by Jan Albert are:

  • Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19, 2020, Cell
  • Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR, 2020, Nature Communications
  • Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • Potential impact of seasonal forcing on a SARS-CoV-2 pandemic, 2020, Swiss Medical Weekly
  • Potential impact of seasonal forcing on a SARS-CoV-2 pandemic, 2020, bioRxiv (Cold Spring Harbor Laboratory)

Jan Albert frequently collaborates with other researchers, including:

  • Robert Dyrdak
  • Ben Murrell
  • Daniel J. Sheward
  • Gunilla B. Karlsson Hedestam
  • Sandra Muschiol

Best Publications

  • Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.

    Takuya Sekine;André Perez-Potti;Olga Rivera-Ballesteros;Kristoffer Strålin

  • Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations.

    Andreas Meyerhans;Rémi Cheynier;Jan Albert;Martina Seth

  • Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype.

    Åsa Björndal;Hongkui Deng;Marianne Jansson;José R. Fiore

  • REPLICATIVE CAPACITY OF HUMAN IMMUNODEFICIENCY VIRUS FROM PATIENTS WITH VARYING SEVERITY OF HIV INFECTION

    Birgitta Åsjö;Jan Albert;Anders Karlsson;Linda Morfeldt-Månson

  • The Physics of the B Factories

    A. J. Bevan;B. Golob;Th Mannel;S. Prell

  • Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.

    Jan Albert;Bengt Abrahamsson;Karoly Nagy;Elisabeth Aurelius

  • Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates.

    E M Fenyö;L Morfeldt-Månson;F Chiodi;B Lind

  • Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy.

    Monique Nijhuis;Rob Schuurman;Dorien de Jong;John Erickson

  • Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR

    Ioanna Smyrlaki;Martin Ekman;Antonio Lentini;Nuno Rufino de Sousa

  • Primary Human Immunodeficiency Virus Type 2 (HIV-2) Isolates, Like HIV-1 Isolates, Frequently Use CCR5 but Show Promiscuity in Coreceptor Usage

    Andreas Mörner;Åsa Björndal;Jan Albert;Vineet N. KewalRamani

  • Simple, sensitive, and specific detection of human immunodeficiency virus type 1 in clinical specimens by polymerase chain reaction with nested primers.

    J Albert;E M Fenyö

  • Potential impact of seasonal forcing on a SARS-CoV-2 pandemic.

    Richard A Neher;Robert Dyrdak;Valentin Druelle;Emma B Hodcroft

  • Differences in chemokine coreceptor usage between genetic subtypes of HIV-1.

    Charlotte Tscherning;Annette Alaeus;Robert Fredriksson;Åsa Björndal

  • Accurate reconstruction of a known HIV-1 transmission history by phylogenetic tree analysis

    Thomas Leitner;David Escanilla;Christer Franzen;Mathias Uhlen

  • Transmission of Drug-Resistant HIV-1 Is Stabilizing in Europe

    Jurgen Vercauteren;Annemarie M. J. Wensing;David A. M. C. van de Vijver;Jan Albert

  • Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys.

    Per Putkonen;Rigmor Thorstensson;Lili Ghavamzadeh;Jan Albert

  • Full Genome Sequences of Human Immunodeficiency Virus Type 1 Subtypes G and A/G Intersubtype Recombinants

    Jean K. Carr;Mika O. Salminen;Jan Albert;Eric Sanders-Buell

  • Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis

    Soo Yon Rhee;Jose Luis Blanco;Michael R. Jordan;Jonathan Taylor

  • Constraints on the off-shell Higgs boson signal strength in the high-mass ZZ and WW final states with the ATLAS detector

    G. Aad;B. Abbott;J. Abdallah;O. Abdinov

  • Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19

    Takuya Sekine;André Perez-Potti;Olga Rivera-Ballesteros;Kristoffer Strålin

Frequent Co-Authors

Eva Maria Fenyö
Eva Maria Fenyö Lund University
Anders Sönnerborg
Anders Sönnerborg Karolinska Institute
Thomas Leitner
Thomas Leitner Los Alamos National Laboratory
Richard A. Neher
Richard A. Neher University of Basel
Francesca Chiodi
Francesca Chiodi Karolinska Institute
Anne-Mieke Vandamme
Anne-Mieke Vandamme Rega Institute for Medical Research
Charles A. Boucher
Charles A. Boucher Erasmus University Rotterdam
Gunnel Biberfeld
Gunnel Biberfeld Karolinska Institute
Magnus Gisslén
Magnus Gisslén Sahlgrenska University Hospital
Gabriella Scarlatti
Gabriella Scarlatti Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related healthcare degrees can open diverse career paths. Advanced nursing degrees, such as the Doctor of Nursing Practice, offer specialized career opportunities. Understanding the dnp salary by specialty can help guide your choices toward the most rewarding fields.

Nurses aiming to advance their clinical expertise might consider acnp programs. These programs prepare family nurse practitioners to handle acute care settings, expanding their scope and potential impact in patient care.

For those seeking an expedited route, enrollment in an accelerated np program offers a streamlined pathway to becoming a nurse practitioner. These programs are particularly beneficial for professionals transitioning from other fields or non-nursing backgrounds.

Speaking of non-nurses, many universities now provide flexible online absn programs for non nurses. These programs are designed to equip students with the necessary nursing qualifications, setting the stage for careers in immunology research or clinical practice.

Best Scientists Citing Jan Albert

Trending Scientists

Recently Published Articles